The rufy2 gene is also frequently found mutated in cancer cells, with the most frequent mutations converting it into a strong target for nonsense mediated mRNA decay, thereby decreasing considerably its expression (Shin et al., 2011; Figure 4C). This evidence concerns the gene RUFY2 and cancer.